*Some Market data delayed by 15 mins.

enGene Holdings Inc. Common Stock

Symbol: ENGN (NASDAQ)
7.57 ▼ (-7.06%) -0.575

Company Description:
enGene Holdings Inc is a clinical-stage biotechnology company focused on developing gene therapies to improve the lives of patients. The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.

Key Stats
  • Today's Open: $8.28
  • Today's High: $8.195
  • Today's Low: $7.565
  • Today's Volume: 80.47K
  • Yesterday Close: $8.14
  • Yesterday High: $8.35
  • Yesterday Low: $7.6035
  • Yesterday Volume: 304.67K
  • Last Min Volume: 71
  • Last Min High: $7.565
  • Last Min Low: $7.565
  • Last Min VWAP: $7.565
Company Profile
  • Name: enGene Holdings Inc. Common Stock
  • Website: https://www.engene.com
  • Listed Date: 2023-11-01
  • Location: SAINT-LAURENT, A8
  • Market Status: Active
  • CIK Number: 0001980845
  • SIC Code: 2836
  • SIC description: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
  • Market Cap: $396.74M
  • Round Lot: 100
  • Outstanding Shares: 51.19M
  • Asset Type: CS
RECENT FILINGS FOR ENGN
Filing Date Filing Type Format
2025-10-02 8-K View
2025-10-02 8-K/A View
2025-10-01 4 View
2025-10-01 3 View
2025-09-30 8-K View
2025-09-11 S-8 View
2025-09-11 10-Q View
2025-09-11 8-K View
2025-09-03 8-K View
2025-07-14 4 View
2025-07-14 3 View
2025-07-10 4 View
2025-07-10 4 View
2025-07-10 4 View
2025-07-10 4 View
2025-07-08 3 View
2025-07-08 3 View
2025-07-08 3 View
2025-07-08 3 View
2025-07-08 8-K View

 

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money. Copyright© 2024, 247MarketNews inc.